Role of Connexin 43 increased expression in pulmonary arterial hyperreactivityinduced by the nerve growth factor NGF

g. Cardouat (Bordeaux, France), M. Douard (Bordeaux, France), L. Roubenne (Bordeaux, France), C. Bouchet (Bordeaux, France), Z. Kmecová (Bratislava, Slovakia), P. Robillard (Bordeaux, France), C. Guignabert (Paris, France), L. Tu (Paris, France), F. Delcambre (Bordeaux, France), R. Marthan (Bordeaux, France), B. Muller (Bordeaux, France), C. Guibert (Bordeaux, France), V. Freund-Michel (Bordeaux, France)

Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Session: Pathogenesis and pathophysiology of pulmonary hypertension
Session type: E-poster
Number: 584

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
g. Cardouat (Bordeaux, France), M. Douard (Bordeaux, France), L. Roubenne (Bordeaux, France), C. Bouchet (Bordeaux, France), Z. Kmecová (Bratislava, Slovakia), P. Robillard (Bordeaux, France), C. Guignabert (Paris, France), L. Tu (Paris, France), F. Delcambre (Bordeaux, France), R. Marthan (Bordeaux, France), B. Muller (Bordeaux, France), C. Guibert (Bordeaux, France), V. Freund-Michel (Bordeaux, France). Role of Connexin 43 increased expression in pulmonary arterial hyperreactivityinduced by the nerve growth factor NGF. 584

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Nerve growth factor expression and function in pulmonary arterial hypertension
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010

Potential role of the nerve growth factor NGF in pulmonary arterial hypertension
Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases
Year: 2009


NGF induces pulmonary arterial hyperreactivity through connexin 43 increased expression
Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension
Year: 2020


Expression and role of the nerve growth factor NGF in pulmonary hypertension
Source: Annual Congress 2011 - Pathobiology of experimental pulmonary hypertension
Year: 2011

Increased binding activity of hypoxia inducible factor (HIF)-1α to vascular endothelial growth factor (VEGF) promoter region mediates enhanced vascular permeability in the lung of cystic fibrosis (CF) patients
Source: Eur Respir J 2003; 22: Suppl. 45, 173s
Year: 2003

Transforming growth factor beta induces Beclin-1 in pulmonary arterial endothelial cells
Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Year: 2020


Vascular endothelial growth factor levels in active pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 610s
Year: 2002

Bioavailability of vascular endothelial growth factor (VEGF)? A role in pulmonary fibrosis?
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012

Diaphragmatic angiogenic growth factor mRNA responses to increased ventilation caused by hypoxia and hypercapnia
Source: Eur Respir J 2001; 17: 681-687
Year: 2001



Production of a novel isoform of vascular endothelial growth factor (VEGF) by the normal human lung
Source: Eur Respir J 2006; 28: Suppl. 50, 822s
Year: 2006

Effect of dexamethasone on TNFα-induced expression of vascular endothelial growth factor (VEGF) in human airway smooth muscle cells - role of histone-acetylation
Source: Eur Respir J 2004; 24: Suppl. 48, 695s
Year: 2004

Serum levels of vascular endothelial growth factor in patients with active pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 341s
Year: 2006

PTEN reduces vascular endothelial growth factor–mediated vascular permeability in asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 581s
Year: 2005

A role for vascular endothelial growth factor (VEGF) in fibrosis?
Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung
Year: 2009

Expression and functional analysis of the transforming growth factor (TGF)-β superfamily in pulmonary arterial hypertension: role of PAI-1 in disease progression
Source: Eur Respir J 2007; 30: Suppl. 51, 53s
Year: 2007

Late Breaking Abstract - NGF induces pulmonary arterial hyperreactivity through increased connexin-43 expression: potential role in pulmonary hypertension
Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension
Year: 2018

Interdependence of endothelin-1 and transforming growth factor-β1 on Wnt3a expression in idiopathic pulmonary fibrosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities
Year: 2012


Role of corticosteroids in TNFα-induced expression of vascular endothelial growth factor (VEGF) in human airway smooth muscle cells
Source: Annual Congress 2003 - Cell signalling and cytokines in asthma
Year: 2003


Vascular endothelial growth factor (VEGF) mRNA isoforms in an animal model of acute lung injury
Source: Annual Congress 2003 - Animal models of lung injury: useful or not?
Year: 2003